The share price of Abaxis (ABAX) reached its 52-week high last month and has witnessed some profit booking since then. Given its stretched valuation, we expect a limited upside potential for the stock ...

Abaxis, Inc. ABAX has been gaining investor confidence on consistently positive results. Over the past six months, the company’s share price has outperformed its industry. The stock has gained 67.8% ...

(Reuters) - Top animal health company Zoetis Inc (ZTS.N) will buy Abaxis Inc (ABAX.O) for $1.9 billion (£1.4 billion), looking to capture a bigger slice of the fast-growing market for diagnostics ...

For the quarter, Abaxis reported that revenues grew 9% year-over-year to $57.7 million. The company’s veterinary revenues were up 10% to $47.7 million, it said in a press release. But net income was ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

On Jan 10, we issued an updated research report on Abaxis, Inc.ABAX. The stock carries a Zacks Rank #3 (Hold). This manufacturer of portable Medical (human) and Veterinary (animal) blood analysis ...

UNION CITY, Calif., June 28, 2012 /PRNewswire via COMTEX/ -- Abaxis, Inc. (nasdaqgs:ABAX), a company manufacturing point of care instrumentation and consumables for the medical, veterinary, and ...

Is Abaxis Inc (NASDAQ:ABAX) a sound investment today? Money managers are becoming hopeful. The number of long hedge fund bets went up by 2 lately. In today’s marketplace, there are many metrics ...

SAN FRANCISCO (CN) - After settling a class action accusing it of issuing too many company shares to its executives, Abaxis must pay the attorneys for its shareholders more than a half million dollars ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. Animal health group Zoetis has agreed to purchase Abaxis, a maker of portable blood diagnostic systems ...

Zoetis Inc (NYSE:ZTS), an animal health company, announced a deal to acquire Abaxis Inc (NASDAQ:ABAX), a developer of portable blood analysis systems used in human or veterinary patient care, for $83 ...